Exercise Capacity Improvement by Conduction System Pacing in heArt Failure patieNts Without Compelling CRT inDication

Recruiting N/A Interventional Study
Heart Failure With Reduced Ejection Fraction Heart Failure With Preserved Ejection Fraction Heart Conduction Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
75 (estimated)
Sponsor
University Hospital, Antwerp · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This randomized controlled trial aims to investigate the impact of conduction system pacing in comparison to right ventricular apical pacing on exercise capacity, as measured by peak oxygen uptake (VO2peak), in heart failure patients with indication for pacing but no compelling indication for cardiac resynchronization therapy (CRT). The mechanisms of exercise intolerance in heart failure patients …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patients with heart failure as defined by European Society of Cardiology guidelines * Signs and/or symptoms of heart failure * AND LVEF \<50% OR LVEF ≥50% and objective evidence of cardiac structural and/or functional abnormalities consistent with the presence of LV diastolic d…
Contacts

Andreas Gevaert

038213538

Andreas.gevaert@uza.be

CONTACT

Faro Verelst

038213538

Faro.verelst@uza.be

CONTACT